Prenatal Screening For Smith-Lemli-Opitz Syndrome
NCT00070850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1800
Last updated 2007-07-02
Summary
Smith-Lemli-Opitz Syndrome (SLOS) is a genetic condition that causes mental retardation and other birth defects. This study will evaluate a new prenatal screening test for SLOS.
Conditions
- Smith-Lemli-Opitz Syndrome
- Pregnancy
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Principal Investigators
-
James E. Haddow, M.D. · Foundation for Blood Research
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-04-30
- Completion
- 2005-07-31
Countries
- United States
Study Locations
More Related Trials
-
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
NCT01707433 ·Status: COMPLETED
-
Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
NCT01773278 ·Status: RECRUITING ·Phase: PHASE2
-
The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2
NCT01123863 ·Status: COMPLETED
-
Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008
NCT04995315 ·Status: COMPLETED
-
A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome Sequencing in France
NCT06875089 ·Status: RECRUITING
-
Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
NCT06669949 ·Status: RECRUITING
-
SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
NCT01434745 ·Status: TERMINATED ·Phase: NA
-
AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease
NCT03533673 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Utility of Prenatal Whole Exome Sequencing
NCT03482141 ·Status: COMPLETED ·Phase: NA
-
Screening of Lysosomal Storage Disorders Diseases in Minority Groups
NCT03812042 ·Status: UNKNOWN
-
Longitudinal Studies of the Glycoproteinoses
NCT01891422 ·Status: COMPLETED
-
Study of the Pathophysiology of RNU4ATAC and RTTN Associated Syndromes
NCT06111950 ·Status: RECRUITING ·Phase: NA
-
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
NCT00425607 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS
NCT06249997 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
NCT00344331 ·Status: RECRUITING
-
Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT05731050 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
NCT03882918 ·Status: TERMINATED ·Phase: PHASE3
-
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
NCT05035030 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
NCT01675674 ·Status: TERMINATED
-
A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy
NCT04998812 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
NCT06193928 ·Status: RECRUITING
-
A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
NCT00879034 ·Status: COMPLETED ·Phase: PHASE2
-
Pyruvate Kinase Deficiency Natural History Study
NCT02053480 ·Status: COMPLETED
-
Safety, PK and PD of FLQ-101 in Premature Neonates
NCT07093255 ·Status: RECRUITING ·Phase: PHASE1
-
A Natural History Study of Biomarkers and Clinical Outcomes in Mucopolysaccharidosis Type IIIA (MPS IIIA; Sanfilippo Syndrome)
NCT05523206 ·Status: COMPLETED